Editing Patient Pathways: Colon Cancer (section)

= Available supportive content for cancer patients =

The Croatian translation of several Guides for patients was carried out by the Association of Women with and Treated for Cancer SVE za NJU based on the approval of the European Society for Medical Oncology (ESMO).

'''ESMO Guide for Patients Living with Cancer'''

This Patient Guide to Living with Cancer has been produced by the European Society for Medical Oncology (ESMO) and the European Cancer Patient Coalition (ECPC) in collaboration with the International Psycho-Oncology Society (IPOS) to help you and others like you in this important part of your life.

In this Guide you can find information about support in coping with the new life reality, life after primary treatment, preventive care and long-term follow-up. It will also help you to keep your own health record, i.e. to plan your health care during your life with cancer.

The guide was translated by Dr. sc. Dea Ajduković, and the translation was reviewed by Doc. Dr. sc. Natalija Dedić Plavetić, MD. specialist. int. oncology and on behalf of patients, psychologist Ljiljana Vukota from the SVE za NJU association.

https://www.esmo.org/content/download/131276/2458900/1/ESMO-Vodic-za-Bolesnike-Zivot-s-Rakom.pdf

'''ESMO Personalized Medicine in Oncology: A Patient Guide'''

This patient guide was launched by the ESMO Personalized Medicine Working Group to help patients, family members, and friends better understand the factors that may influence a personalized approach to cancer prevention, diagnosis, and treatment. This brochure presents current knowledge about the basic principles of personalized medicine, illustrating its application in several types of tumors. Personalized medicine is the future of cancer treatment, and for it to become a reality in the near future and enable better treatment of tumors, the role of patients is crucial.

In this expanding and evolving approach, ESMO is committed to educating patients so that they can better understand its main principles and their own contribution to the advancement of therapy.

The Croatian translation of the Guide was made possible by the Association of Women with and Treated for Cancer SVE za NJU based on the approval of the European Society for Medical Oncology (ESMO). The Croatian translation was reviewed by: Prof. Ljiljana Šerman, prof. Floriana Bulić-Jakuš and Mrs. Ljiljana Vukota.

https://www.esmo.org/content/download/385655/7486427/1/HR-Personalizirana-Medicina-u-Onkologiji-Vodic-za-Bolesnike.pdf

'''ESMO Immune-Related Adverse Events and their Management: A Patient Guide'''

This guide was prepared to help you and your family, friends and caregivers better understand immune-related side effects and their management. It contains information on the most common toxicities associated with modern immunotherapies (known as “immune checkpoint inhibitors”), how your oncology team can manage those symptoms, and some steps you can take yourself to reduce their impact. The medical information described in this document is based on the ESMO Clinical Practice Guidelines for the Management of Immune-Related Toxicities, which are designed to assist clinicians in the diagnosis, treatment and follow-up of these events. All ESMO clinical practice guidelines are prepared and reviewed by leading experts using evidence from the latest clinical trials, scientific research and expert opinion.

The Croatian translation of the guide was reviewed by: a representative of the Croatian Society for Internal Oncology: Doc. Dr. sc. Natalija Dedić Plavetić, representative of the Croatian Thoracic Society: Prof. Dr. sc. Marko Jakopović, representative of the Association of Women with and Treated for Cancer ALL for HER: Ljiljana Vukota.

'''ESMO Cancer Treatment During the Covid-19 Pandemic: A Patient Guide'''

The guide contains information about COVID-19 disease and its symptoms, as well as measures you can take to reduce the risk of infection. Also, the guide provides information on the impact of the COVID-19 pandemic on various aspects of cancer treatment, including possible changes to your treatment plan and medical examinations that you may need to protect yourself from infection.

The Croatian translation was reviewed by: Prim. Dr. sc. Paula Podolski, president of the Croatian Senological Society, Doc. Dr. sc. Borislav Belev, internist oncologist, National Representative of the Croatian Society for Internal Oncology at ESMO and Ljiljana Vukota, representative of the SVE za NJU association.

http://www.svezanju.hr/lijecenje-raka-tijekom-pandemije-covid-19-esmo-vodic-za-bolesnike/

'''ESPEN practical guideline: Clinical Nutrition in cancer'''

Malnutrition is a common feature in cancer patients and is a consequence of the presence of the tumor and medical and surgical anti-cancer treatments.

Malnutrition negatively affects quality of life and treatment toxicity, and it is estimated that up to 10-20% of cancer patients die from the consequences of malnutrition, not from the tumor itself. Therefore, nutrition plays a key role in the multimodal treatment of cancer.

Strong evidence shows that nutritional problems should be considered from the time of cancer diagnosis, within the diagnostic and therapeutic pathway, and should run in parallel with anti-cancer treatment. However, worldwide, cancer-related malnutrition is still largely unrecognized, underestimated, and undertreated in clinical practice.

These evidence-based guidelines were developed to translate the current best evidence and expert opinion into recommendations for multidisciplinary teams responsible for identifying, preventing, and managing reversible elements of malnutrition in adult cancer patients.

<span id="directory-of-associations-offering-supportive-activities-to-cancer-patients"></span>